$3.00
0.00 (0%)
SGX Pharmaceuticals, Inc. (NASDAQ:SGXP)
CAPS Rating:
A biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.
A biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.